BRII BIOSCIENCES L
(HKEX: 2137)
Brii Biosciences Ltd. engages in advancing therapies for significant infectious diseases and other illnesses which have significant public health burdens. The firm also focuses on developing therapies for infectious diseases and central nervous system diseases. The company was founded by Zhi Hong on December 8, 2017, and is headquartered in Beijing, China.
1.310 -
-0.010
(-0.76%)
Range
1.270 - 1.310
(3.15%)
Open
1.300
Previous Close
1.320
Bid Price
1.290
Bid Volume
('000)
97
Ask Price
1.310
Ask Volume
('000)
36.5
Volume
('000)
895
Value
1,157,325
Remark
-
Delayed prices. Updated at 13 May 2026 16:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
